Canada’s largest grocer reported C$0.62 adjusted EPS and C$15.27B revenue, driven by drugstore and e-commerce growth.
Loblaw Companies posted second-quarter non-GAAP earnings of C$0.62 per share on revenue of C$15.27 billion, up 4.1% year-over-year. The results aligned with market expectations as food retail same-store sales grew 1.6%, while drug retail same-store sales climbed 4.6%.
Pharmacy and healthcare services led drug retail growth with a 7.5% same-store sales increase, outpacing front-store growth of 1.3%. E-commerce sales surged 19.3%, reflecting continued demand for online grocery and retail services.
The company’s performance highlights resilience in its core segments amid a competitive retail environment, though food retail growth slowed compared to prior periods.